What is MoleMate™?
MoleMate™ is a non-invasive, rapid and painless mole-screening technology which enables physicians to quickly scan a patient’s moles, so they will be able to tell quickly and accurately determine whether treatment is required, or reassure a patient that the mole is benign.
What technology does MoleMate™ utilize?
MoleMate™ uses SIAscopy™, which is a, non-invasive skin-imaging technology that can accurately help physicians detect melanoma at an early and treatable stage, dramatically reducing the need for biopsies and excisions of moles that are not suspicious. The process uses non-harmful light and digital imaging to evaluate the patient’s skin.
What does the word SIAscopy™ mean?
SIAscopy™ is Spectrophotometric Intracutaneous Analysis, and utilizes a handheld LED-Light based spectrophotometer. SIAscopy™ projects visible and infra-red light to create an image of key components just beneath the patient’s skin.
SIAscopy™ reveals the position, spatial distribution, and concentration of, epidermal pigment, dermal pigment, haemoglobin, and collagen, representing important and critical markers to determine the state or condition of the mole or lesion.
What can be seen using MoleMate™ (SIAscopy™)?
SIAscopy™ is the only technology that can look 2mm beneath the skin’s surface to provide five distinct images to aid in physicians’ diagnosis:
Dermatoscopic view – A clear and magnified view of the mole as it appears on the surface of the patient’s skin, helping physicians identify important features.
Pigment view – This view confirms to physicians that the mole is a pigmented lesion
Dermal pigment view – Establishes the presence and distribution of pigment I the deeper layers of the skin. This may be important in differentiating a suspicious from a non-suspicious mole.
Blood supply view – This view shows changes in blood supply that can be early indicators of suspicious moles.
Collagen view – Assists assessment of the damage to lower layers of the skin, providing more information about damage to lower layers of the skin and further assisting identification of suspicious moles.
How do the five views (dermoscopy, pigment, dermal pigment, haemoglobin, and collagen) aid diagnosis?
Within seconds, the MoleMate proprietary software creates pictures giving the physician:
- True digital dermatoscopic colour image
- Ability to see in-vivo pathological characteristics at the time of the clinical exam
- Ability to catalogue, monitor, and compare lesions over time
- Share data with other physicians
- Share image during patient exam/counselling
How can physicians get trained in this technology?
MoleMate™ comes with an interactive training CD which has been documented to improve primary care physicians’ sensitivity and specificity over clinical assessment alone in less than 2 hours, resulting in an increase in the number of melanomas diagnosed, and an increase in the quality of referrals.
How is MoleMate™ integrated into the patient examination?
First the patient’s skin is visually inspected, then, using the hand-held MoleMate™ SIAscope™, each mole that requires detailed examination is quickly and painlessly scanned. Images are displayed on a computer screen and analyzed by the physician during the examination.
Can MoleMate™ generate a report?
MoleMate can generate a clear, concise PDF report for patient records/referrals.
What are the reimbursement codes for MoleMate™?
It is recommended that until a specific SIAscopy™ code is obtained from the AMA, that physicians bill for dermoscopy, and attach a copy of the PDF report. The first view generated in MoleMate™ is a digital dermoscopic view. Some insurance carriers prefer to only pay in patients with a personal or family history of suspicious moles.
Note: For physicians that typically would have referred patients after visual inspection of suspicious moles, they may now, with SIAscopy™, be able to more confidently manage these moles in their own practice, billing for the performed procedure (cutting, biopsy, freezing) following the use of MoleMate™.